The association between aldosterone and lipid profiles in patients with primary aldosteronism
- PMID: 40082504
- PMCID: PMC11906652
- DOI: 10.1038/s41598-025-92477-9
The association between aldosterone and lipid profiles in patients with primary aldosteronism
Abstract
Previous studies have yielded inconsistent findings regarding the comparison of lipid profiles in patients with primary aldosteronism (PA) and essential hypertension (EH), and there is a limited understanding of the association between plasma aldosterone concentration (PAC) and lipid profiles across various populations. 270 patients with PA and 598 patients with EH diagnosed at the Second Affiliated Hospital of Nanchang University from January 2020 to June 2021 were consecutively included. After 1:1 propensity score matching by sex, age, and body mass index (BMI), 267 PA and 267 EH patients were ultimately enrolled in the study. The relationship between PAC and lipids was explored. Compared with EH patients, PA patients showed significantly lower levels of total cholesterol (TC) (P = 0.003), low-density lipoprotein cholesterol (LDL-C) (P < 0.001) and non-high-density lipoprotein cholesterol (Non-HDL-C) (P = 0.014). Log TC (P = 0.0256), log triglyceride (TG) (P = 0.0497) and log Non-HDL-C (P = 0.0184) levels were negatively correlated with log PAC in PA patients. Consistently, these lipids yielded similar results with aldosterone/renin ratio (ARR). However, the correlation does not exist in EH patients. The levels of TC, LDL-C and Non-HDL-C were significantly lower in PA than in EH patients. And a significant independent inverse association between log TC, log TG, log Non-HDL-C, and log PAC levels in PA patients. However, the above associations were not always present in clinically matched EH patients.
Keywords: Aldosterone; Dyslipidemia; Essential hypertension; Primary aldosteronism.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: This study was approved by the ethics committee of the Second Affiliated Hospital of Nanchang University and was part of the study of the Nanchang Primary Aldosteronism Study (IIT-O-2021-032). It was registered on chictr.org (ChiCTR2200057297). Signed informed consent was obtained from each patient before participation.
Figures


Similar articles
-
Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study.Endocrinol Metab (Seoul). 2021 Aug;36(4):885-894. doi: 10.3803/EnM.2021.1012. Epub 2021 Aug 10. Endocrinol Metab (Seoul). 2021. PMID: 34372626 Free PMC article.
-
The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.BMC Endocr Disord. 2022 Aug 31;22(1):217. doi: 10.1186/s12902-022-01135-y. BMC Endocr Disord. 2022. PMID: 36045354 Free PMC article.
-
Effect of Age on Aldosterone-Renin Ratio in Screening Primary Aldosteronism.J Clin Hypertens (Greenwich). 2025 Mar;27(3):e70014. doi: 10.1111/jch.70014. J Clin Hypertens (Greenwich). 2025. PMID: 40065694 Free PMC article.
-
Association of Plasma Aldosterone Concentration With Early Renal Injury Biomarkers in Primary Aldosteronism: A Propensity-Matched Comparative Study.J Clin Hypertens (Greenwich). 2025 Aug;27(8):e70124. doi: 10.1111/jch.70124. J Clin Hypertens (Greenwich). 2025. PMID: 40845199 Free PMC article.
-
[Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Sep 24;44(9):743-749. doi: 10.3760/cma.j.issn.0253-3758.2016.09.003. Zhonghua Xin Xue Guan Bing Za Zhi. 2016. PMID: 27667270 Chinese.
Cited by
-
Novel predictive factors scoring model for persistent hypertension after adrenalectomy in patients with primary aldosteronism.Sci Rep. 2025 May 29;15(1):18935. doi: 10.1038/s41598-025-03912-w. Sci Rep. 2025. PMID: 40442280 Free PMC article.
References
-
- Catapano, A. L. et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur. Heart J.37, 2999–3058. 10.1093/eurheartj/ehw272 (2016). - PubMed
-
- Turchi, F. et al. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. Nutr. Metab. Cardiovasc. Dis.24, 476–482. 10.1016/j.numecd.2013.09.009 (2014). - PubMed
-
- Milliez, P. et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol.45, 1243–1248. 10.1016/j.jacc.2005.01.015 (2005). - PubMed
-
- Monticone, S. et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol.6, 41–50. 10.1016/S2213-8587(17)30319-4 (2018). - PubMed
-
- Savard, S., Amar, L., Plouin, P. F. & Steichen, O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension62, 331–336. 10.1161/HYPERTENSIONAHA.113.01060 (2013). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous